Ignatia Amara 30x Globule
NDC Package 73296-014-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ignatia Amara 30x (ignatia amara) globules is for sleeplessness, nervousness, and headaches mood swings due to emotional distress*. This formulation utilizes a globule delivery system. Marketed by Laboratoire Schmidt-nagel Inc., this product is identified by NDC 73296-014.

Identification & Billing

NDC Package Code
73296-014-01
Package Description
4 g in 1 TUBE
Product Code
73296-014
11-Digit Billing Format
73296001401

Clinical Specifications

Proprietary Name
Ignatia Amara 30x
Non-Proprietary Name
Ignatia Amara
Substance Name
Strychnos Ignatii Seed
Dosage Form
Globule - Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade.
Administration Route
  • Oral - Administration to or by way of the mouth.
  • Sublingual - Administration beneath the tongue.
Active Ingredient(s)
STRYCHNOS IGNATII SEED 30 [hp_X]/g
Usage Information
For sleeplessness, nervousness, and headaches mood swings due to emotional distress*

Regulatory & Marketing

Labeler Name
Laboratoire Schmidt-nagel Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
05-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73296-014-01 identifies a specific commercial package of 4 g in 1 tube of Ignatia Amara 30x, a human over the counter drug labeled by Laboratoire Schmidt-nagel Inc.. This globule is formulated for oral; sublingual use and contains strychnos ignatii seed as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laboratoire Schmidt-nagel Inc. on May 01, 2025. The current certification is valid through December 31, 2026.

How is this Laboratoire Schmidt-nagel Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73296001401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73296-014-01
11-Digit CMS (5-4-2)
73296-0014-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.